Utility of cell-free dna from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules
Utility of cell-free dna from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT BACKGROUND Bronchial washing fluid (BWF) is a less-invasive specimen. Due to the limited sensitivity of BWF cellular component diagnosis, the aim of this study was to explore the
potential role of BWF supernatant as a source of liquid biopsy of lung cancer. METHODS This prospective study enrolled 76 suspected and 5 progressed lung cancer patients. Transbronchial
biopsy tissues, BWF supernatant (BWF_Sup) and BWF precipitant (BWF_Pre) were tested by a targeted panel of 1021 genes. RESULTS BWF_Sup cell-free DNA (cfDNA) was superior to tissue biopsy and
BWF_Pre in determining mutational allele frequency, tumour mutational burden, and chromosomal instability. Moreover, BWF_Sup and BWF_Pre achieved comparable efficacy to tissue samples in
differentiating malignant and benign patients, but only BWF_Sup persisted differentiated performance after excluding 55 malignancies pathologically diagnosed by bronchoscopic biopsy. Among
67 malignant patients, 82.1% and 71.6% of tumour-derived mutations (TDMs) were detected in BWF_Sup and BWF_Pre, respectively, and the detectability of TDMs in BWF_Sup was independent of the
cytological examination of BWF. BWF_Sup outperformed BWF_Pre in providing more subclonal information and thus might yield advantage in tracking drug-resistant markers. CONCLUSIONS BWF_Sup
cfDNA is a reliable medium for lung cancer diagnosis and genomic profiles and may provide important information for subsequent therapeutic regimens. Access through your institution Buy or
subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 24 print issues and online
access $259.00 per year only $10.79 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which
are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS
PROPOSAL OF A NOVEL PIPELINE INVOLVING PRECISE BRONCHOSCOPY OF DISTAL PERIPHERAL PULMONARY LESIONS FOR GENETIC TESTING Article Open access 17 November 2022 COMPARATIVE ANALYSIS OF EGFR
MUTATIONS IN CIRCULATING TUMOR DNA AND PRIMARY TUMOR TISSUES FROM LUNG CANCER PATIENTS USING BEAM_ING_ PCR Article Open access 08 January 2025 MOLECULAR CHARACTERISTICS OF PRIMARY PULMONARY
LYMPHOEPITHELIOMA-LIKE CARCINOMA BASED ON INTEGRATED GENOMIC ANALYSES Article Open access 08 January 2021 DATA AVAILABILITY The datasets supporting the conclusions of this article are
available from the corresponding author on reasonable request. REFERENCES * Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the
epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–39. Article CAS PubMed Google Scholar * Soda M, Choi
YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561–6. Article CAS PubMed
Google Scholar * Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with
advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012;13:239–46. Article CAS PubMed Google Scholar
* Lee CK, Davies L, Wu YL, Mitsudomi T, Inoue A, Rosell R, et al. Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of
overall survival. J Natl Cancer Inst. 2017;109:djw279. * Lim C, Tsao MS, Le LW, Shepherd FA, Feld R, Burkes RL, et al. Biomarker testing and time to treatment decision in patients with
advanced nonsmall-cell lung cancer. Annal Oncol. 2015;26:1415–21. Article CAS Google Scholar * Aucamp J, Bronkhorst AJ, Badenhorst CPS, Pretorius PJ. The diverse origins of circulating
cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev Camb Philos Soc. 2018;93:1649–83. Article PubMed Google Scholar * Pessoa LS, Heringer M, Ferrer VP.
ctDNA as a cancer biomarker: a broad overview. Crit Rev Oncol/Hematol. 2020;155:103109. Article PubMed Google Scholar * Schrock AB, Welsh A, Chung JH, Pavlick D, Bernicker EH, Creelan BC,
et al. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer. J Thorac Oncol. 2019;14:255–64. Article CAS PubMed Google
Scholar * Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med.
2014;20:548–54. Article CAS PubMed PubMed Central Google Scholar * Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, et al. Circulating tumor DNA analysis in patients with
cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol. 2018;36:1631–41. Article CAS PubMed Google Scholar * Diehl F, Schmidt K,
Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14:985–90. Article CAS PubMed Google Scholar * Thompson JC, Yee SS, Troxel AB,
Savitch SL, Fan R, Balli D, et al. Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating
tumor DNA. Clin Cancer Res. 2016;22:5772–82. Article CAS PubMed PubMed Central Google Scholar * Reckamp KL, Melnikova VO, Karlovich C, Sequist LV, Camidge DR, Wakelee H, et al. A highly
sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma. J Thorac Oncol. 2016;11:1690–700. Article PubMed Google Scholar * De Mattos-Arruda L,
Mayor R, Ng CKY, Weigelt B, Martínez-Ricarte F, Torrejon D, et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.
Nat Commun. 2015;6:8839. Article PubMed PubMed Central Google Scholar * Shin S, Kim J, Kim Y, Cho SM, Lee KA. Assessment of real-time PCR method for detection of EGFR mutation using both
supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients. Clin Chem Lab Med. 2017;55:1962–9. Article CAS PubMed Google Scholar * Li YS,
Jiang BY, Yang JJ, Zhang XC, Zhang Z, Ye JY, et al. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a
new medium of liquid biopsy. Annal Oncol. 2018;29:945–52. Article CAS Google Scholar * Zhai J, Han S, Guo Q, Shan B, Wang J, Guo Y, et al. Identifying genomic alterations in small cell
lung cancer using the liquid biopsy of bronchial washing fluid. Front Oncol. 2021;11:647216. Article PubMed PubMed Central Google Scholar * Ryu JS, Lim JH, Lee MK, Lee SJ, Kim HJ, Kim
MJ, et al. Feasibility of bronchial washing fluid-based approach to early-stage lung cancer diagnosis. Oncologist. 2019;24:e603–e6. Article CAS PubMed PubMed Central Google Scholar *
Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B, et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in
patients with non-small-cell lung cancer. Clin Cancer Res. 2006;12:3915–21. Article CAS PubMed Google Scholar * Nahar R, Zhai W, Zhang T, Takano A, Khng AJ, Lee YY, et al. Elucidating
the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing. Nat Commun. 2018;9:216. Article PubMed PubMed Central Google Scholar * Parikh AR,
Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, et al. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nat Med.
2019;25:1415–21. Article CAS PubMed PubMed Central Google Scholar * Lin G, Li C, Li PS, Fang WZ, Xu HP, Gong YH, et al. Genomic origin and EGFR-TKI treatments of pulmonary
adenosquamous carcinoma. Ann Oncol. 2020;31:517–24. Article CAS PubMed Google Scholar * Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, et al. Integrating genomic
features for non-invasive early lung cancer detection. Nature. 2020;580:245–51. Article CAS PubMed PubMed Central Google Scholar * Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C,
et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333–9. Article CAS PubMed PubMed Central Google Scholar * Cibulskis K, Lawrence MS, Carter
SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213–9. Article CAS PubMed
PubMed Central Google Scholar * Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, et al. CONTRA: copy number analysis for targeted resequencing. Bioinformatics.
2012;28:1307–13. Article PubMed PubMed Central Google Scholar * Mroz EA, Rocco JW. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and
neck squamous cell carcinoma. Oral Oncol. 2013;49:211–5. Article CAS PubMed Google Scholar * Roth A, Khattra J, Yap D, Wan A, Laks E, Biele J, et al. PyClone: statistical inference of
clonal population structure in cancer. Nat Methods. 2014;11:396–8. Article CAS PubMed PubMed Central Google Scholar * Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et
al. Oncogenic signaling pathways in the cancer genome atlas. Cell. 2018;173:321–37.e10 Article CAS PubMed PubMed Central Google Scholar * Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn
L, Steins M, et al. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N Engl J Med. 2017;376:2415–26. Article CAS PubMed PubMed Central Google Scholar * Miller
RJ, Casal RF, Lazarus DR, Ost DE, Eapen GA. Flexible bronchoscopy. Clin chest Med. 2018;39:1–16. Article PubMed Google Scholar * Zhang SJ, Zhang M, Zhou J, Zhang QD, Xu QQ, Xu X.
Comparison of radial endobronchial ultrasound with a guide sheath and with distance by thin bronchoscopy for the diagnosis of peripheral pulmonary lesions: a prospective randomized crossover
trial. J Thorac Dis. 2016;8:3112–8. Article PubMed PubMed Central Google Scholar * Schmidt B, Carstensen T, Engel E, Jandrig B, Witt C, Fleischhacker M. Detection of cell-free nucleic
acids in bronchial lavage fluid supernatants from patients with lung cancer. Eur J Cancer. 2004;40:452–60. Article CAS PubMed Google Scholar * Carstensen T, Schmidt B, Engel E, Jandrig
B, Witt C, Fleischhacker M. Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer. Ann N. Y Acad Sci. 2004;1022:202–10. Article CAS PubMed Google
Scholar * Cardarella S, Ortiz TM, Joshi VA, Butaney M, Jackman DM, Kwiatkowski DJ, et al. The introduction of systematic genomic testing for patients with non-small-cell lung cancer. J
Thorac Oncol. 2012;7:1767–74. Article CAS PubMed Google Scholar * Herth FJ, Ernst A, Becker HD. Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules
and peripheral lesions. Eur Respiratory J. 2002;20:972–4. Article CAS Google Scholar * Guan Y, Hu H, Peng Y, Gong Y, Yi Y, Shao L, et al. Detection of inherited mutations for hereditary
cancer using target enrichment and next generation sequencing. Fam Cancer. 2015;14:9–18. Article PubMed Google Scholar * Qu S, Chen Q, Yi Y, Shao K, Zhang W, Wang Y, et al. A reference
system for BRCA mutation detection based on next-generation sequencing in the Chinese population. J Mol Diagn. 2019;21:677–86. Article CAS PubMed Google Scholar * Zhang Y, Yao Y, Xu Y,
Li L, Gong Y, Zhang K, et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun. 2021;12:11. Article CAS PubMed PubMed Central Google Scholar * Liu
X, Wang F, Xu C, Chen X, Hou X, Li Q, et al. Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid
carcinoma. Oncogene. 2021;40:821–32. Article CAS PubMed Google Scholar * Hu C, Zhao L, Liu W, Fan S, Liu J, Liu Y, et al. Genomic profiles and their associations with TMB, PD-L1
expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers. J Immunother Cancer. 2021;9:e003773. * Pantel K, Alix-Panabières C. Circulating tumour cells
in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16:398–406. Article PubMed Google Scholar * Pérez-Callejo D, Romero A, Provencio M, Torrente M. Liquid biopsy based
biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring. Transl Lung Cancer Res. 2016;5:455–65. Article PubMed PubMed Central Google Scholar * Alix-Panabières C,
Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 2016;6:479–91. Article PubMed Google Scholar * Zhong WZ, Wang Q, Mao
WM, Xu ST, Wu L, Shen Y, et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label,
phase 3 study. Lancet Oncol. 2018;19:139–48. Article CAS PubMed Google Scholar * Harris FR, Kovtun IV, Smadbeck J, Multinu F, Jatoi A, Kosari F, et al. Quantification of somatic
chromosomal rearrangements in circulating cell-free DNA from ovarian cancers. Sci Rep. 2016;6:29831. Article CAS PubMed PubMed Central Google Scholar * Dong X, Fernandez-Salas E, Li E,
Wang S. Elucidation of resistance mechanisms to second-generation ALK inhibitors alectinib and ceritinib in non-small cell lung cancer cells. Neoplasia. 2016;18:162–71. Article CAS PubMed
PubMed Central Google Scholar * Zhang X, Li C, Ye M, Hu Q, Hu J, Gong Z, et al. Bronchial washing fluid versus plasma and bronchoscopy biopsy samples for detecting epidermal growth
factor receptor mutation status in lung cancer. Front Oncol. 2021;11:602402. Article PubMed PubMed Central Google Scholar * Zhou C, Yuan Z, Ma W, Qi L, Mahavongtrakul A, Li Y, et al.
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors. J Hematol Oncol. 2018;11:129. Article CAS PubMed
PubMed Central Google Scholar * Zheng D, Ye X, Zhang MZ, Sun Y, Wang JY, Ni J, et al. Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with
acquired EGFR-TKI resistance. Sci Rep. 2016;6:20913. Article CAS PubMed PubMed Central Google Scholar * Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of
circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra24. Article PubMed PubMed Central Google Scholar * Tong L, Ding N, Tong X, Li J, Zhang Y,
Wang X, et al. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019;9:5532–41.
Article CAS PubMed PubMed Central Google Scholar Download references ACKNOWLEDGEMENTS Prior abstract presentation: Oral presentation, Tumour-derived cell-free DNA from bronchoalveolar
lavage fluid (BALF): a potential liquid biopsy analysis in lung cancer patients; April 3, 2019, American Association for Cancer Research (AACR) Annual Meeting, Atlanta, USA. FUNDING None.
AUTHOR INFORMATION Author notes * These authors contributed equally: Xinyu Zhang, Zhuo Yu, Yaping Xu. AUTHORS AND AFFILIATIONS * Zhongshan Hospital, Fudan University, No. 180 Fenglin Road,
Xuhui District, 200032, Shanghai, China Xinyu Zhang, Yencheng Chao, Qin Hu, Chun Li, Maosong Ye, Yingyong Hou & Xin Zhang * Beijing Tsinghua Changgung Hospital, 168 Litang Road,
Changping District, 102218, Beijing, China Zhuo Yu * Geneplus-Beijing Institute, 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, 102206,
Beijing, China Yaping Xu, Xiuli Zhu, Liang Cui, Jing Bai, Yuhua Gong, Yanfang Guan & Xuefeng Xia * Ruijin Hospital, Shanghai Jiao Tong University, No. 197 Ruijin Second Road, Huangpu
District, 200025, Shanghai, China Min Zhou * First People’s Hospital, Suzhou University, No. 899 Pinghai Road, Gusu District, 215008, Suzhou, China Jian’an Huang * Zhengzhou Central
Hospital, Zhengzhou University, No. 195 Tongbai Road, Zhongyuan District, 450000, Zhengzhou, China Hua Zhang * Shanghai Sixth People’s Hospital, No 600 Yishan Road, Xuhui District, 200233,
Shanghai, China Tao Ren * First Affiliated Hospital of Zhejiang University, No. 79 Qingchun Road, Shangcheng District, 310002, Hangzhou, China Qian Shen * Fourth Affiliated Hospital of
Zhejiang University, No 88 Jiefang Road, Shangcheng District, 310002, Hangzhou, China Kai Wang * Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the affiliated Cancer Hospital
of Xiangya School of Medicine, Central South University, 283 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, China Xingxiang Pu * Comprehensive Cancer Center, The Ohio State
University, 460W 12th Ave., Columbus, OH, 43210, USA David P. Carbone Authors * Xinyu Zhang View author publications You can also search for this author inPubMed Google Scholar * Zhuo Yu
View author publications You can also search for this author inPubMed Google Scholar * Yaping Xu View author publications You can also search for this author inPubMed Google Scholar *
Yencheng Chao View author publications You can also search for this author inPubMed Google Scholar * Qin Hu View author publications You can also search for this author inPubMed Google
Scholar * Chun Li View author publications You can also search for this author inPubMed Google Scholar * Maosong Ye View author publications You can also search for this author inPubMed
Google Scholar * Xiuli Zhu View author publications You can also search for this author inPubMed Google Scholar * Liang Cui View author publications You can also search for this author
inPubMed Google Scholar * Jing Bai View author publications You can also search for this author inPubMed Google Scholar * Yuhua Gong View author publications You can also search for this
author inPubMed Google Scholar * Yanfang Guan View author publications You can also search for this author inPubMed Google Scholar * Min Zhou View author publications You can also search for
this author inPubMed Google Scholar * Jian’an Huang View author publications You can also search for this author inPubMed Google Scholar * Hua Zhang View author publications You can also
search for this author inPubMed Google Scholar * Tao Ren View author publications You can also search for this author inPubMed Google Scholar * Qian Shen View author publications You can
also search for this author inPubMed Google Scholar * Kai Wang View author publications You can also search for this author inPubMed Google Scholar * Yingyong Hou View author publications
You can also search for this author inPubMed Google Scholar * Xuefeng Xia View author publications You can also search for this author inPubMed Google Scholar * Xingxiang Pu View author
publications You can also search for this author inPubMed Google Scholar * David P. Carbone View author publications You can also search for this author inPubMed Google Scholar * Xin Zhang
View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS Prof. Xin Zhang is the guarantor of the content of the manuscript, including the data and
analysis. Xinyu Zhang and YX had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. ZY, Yencheng Chao,
QH, CL, MY, X Zhu, LC, JB, Y Gong, Y Guan, MZ, JH, HZ, TR, QS, KW, YH, XX, DPC and XP contributed substantially to the study design, data analysis and interpretation, and the writing of the
manuscript. CORRESPONDING AUTHORS Correspondence to Xingxiang Pu, David P. Carbone or Xin Zhang. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ETHICS
APPROVAL AND CONSENT TO PARTICIPATE This study was approved by the Ethics Committee of the Zhongshan Hospital of Fudan University (No. B2018-027) and complied with all relevant ethical
regulations. All participating patients signed written informed consent. CONSENT TO PUBLISH Not applicable. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with
regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTARY FMATERIAL TABLE S1 TABLE S2 TABLE S3 TABLE S4 TABLE S5 TABLE S6
TABLE S7 FORM RIGHTS AND PERMISSIONS Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author
self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE
CITE THIS ARTICLE Zhang, X., Yu, Z., Xu, Y. _et al._ Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules.
_Br J Cancer_ 127, 2154–2165 (2022). https://doi.org/10.1038/s41416-022-01969-2 Download citation * Received: 12 July 2021 * Revised: 05 July 2022 * Accepted: 23 August 2022 * Published: 17
October 2022 * Issue Date: 07 December 2022 * DOI: https://doi.org/10.1038/s41416-022-01969-2 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content:
Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
Trending News
Tv channel crew attacked by women in dadri; cameraperson injured* Home * Viral * TV channel crew attacked by women in Dadri; cameraperson injured THE CREW OF NDTV WAS ALSO ATTACKED BY ...
Illinois pre-k teacher is found dead in car with state trooper husband in apparent murder-suicideA pre-kindergarten teacher was fatally shot Monday by her Illinois State Trooper husband, who then turned the gun on him...
Obituaries - Oct. 21, 1996 - Los Angeles TimesTom Girardi was a legal legend—until he was found guilty of stealing millions from his own clients. Host Madison McGhee ...
Gop tax cut plan survives challenges, heads for vote : congress: measure goes to house floor essentially intact after amendments are defeated. Child cWASHINGTON — House Republicans on Tuesday fought off dozens of challenges to their plan to cut taxes by $189 billion ove...
The five most wonderful road trips around the worldThe North Coast 500 route in Scotland, also popularly referred to as NC500, spans around 830 kilometers, and takes most ...
Latests News
Utility of cell-free dna from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesABSTRACT BACKGROUND Bronchial washing fluid (BWF) is a less-invasive specimen. Due to the limited sensitivity of BWF cel...
EB-1A | TechCrunchSAVE NOW THROUGH JUNE 4 FOR TECHCRUNCH SESSIONS: AI SAVE $300 ON YOUR TICKET TO TC SESSIONS: AI—AND GET 50% OFF A SECOND...
Research: land use challenges for indonesia’s transition to renewable energyThe world’s fourth-highest emitter of greenhouse gases, Indonesia, is heavily reliant on coal to generate electricity. I...
Sean ‘diddy’ combs’ employees were ‘required’ to carry pink cocaine — same drug found in liam payne’s system: suitA popular drug found in Liam Payne’s system after his death is the same substance that Sean “Diddy” Combs’ employees wer...
How to (re)design an app in 2 weeks — a ui/ux case study0. INTRODUCTION Over a year ago, our startup Moovle launched its app to the public. Our first MVP functioned well and we...